Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Liabilities from Discontinued Operations (2019 - 2020)

Cumberland Pharmaceuticals (CPIX) has disclosed Liabilities from Discontinued Operations for 2 consecutive years, with 1247011.0 as the latest value for Q1 2020.

  • Quarterly Liabilities from Discontinued Operations changed N/A to 1247011.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was 1247011.0 through Mar 2020, changed N/A year-over-year, with the annual reading at 2151357.0 for FY2019, N/A changed from the prior year.
  • Liabilities from Discontinued Operations hit 1247011.0 in Q1 2020 for Cumberland Pharmaceuticals, down from 2151357.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 2151357.0 in Q4 2019 to a low of 1247011.0 in Q1 2020.